Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase

Infection and Immunity

Volumn 79, Issue 6, 2011, Pages 2385-2395

  Rocco, Nicole M ^a   Carmen, John C ^a   Klein, Bruce S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; BLASTOMYCES DERMATITIDIS; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; FUNGAL VIRULENCE; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; UPREGULATION; YEAST CELL;

ANIMALS; BLASTOMYCES; BLASTOMYCOSIS; BLOTTING, WESTERN; CELL LINE; HOST-PATHOGEN INTERACTIONS; MACROPHAGES, ALVEOLAR; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79959435728     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01249-10     Document Type: Article

References (37)

1. Alderton, W. K., C. E. Cooper, and R. G. Knowles. 2001. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:593-615.
2. Allendoerfer, R., and G. S. Deepe, Jr. 1998. Blockade of endogenous TNFalpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160:6072-6082.
3. Bradsher, R. W., Jr. 2008. Pulmonary blastomycosis. Semin. Respir. Crit. Care Med. 29:174-181.
4. Brummer, E., P. A. Morozumi, D. E. Philpott, and D. A. Stevens. 1981. Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro. Infect. Immun. 32:864-871.
5. Brummer, E., and D. A. Stevens. 1987. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin. Exp. Immunol. 70:520-528.
6. Chao, L. Y., J. Rine, and M. A. Marletta. 2008. Spectroscopic and kinetic studies of Nor1, a cytochrome P450 nitric oxide reductase from the fungal pathogen Histoplasma capsulatum. Arch. Biochem. Biophys. 480:132-137.
7. Chow, E. D., O. W. Liu, S. O'Brien, and H. D. Madhani. 2007. Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature. Curr. Genet. 52:137-148.
8. Chu, J. H., C. Feudtner, K. Heydon, T. J. Walsh, and T. E. Zaoutis. 2006. Hospitalizations for endemic mycoses: a population-based national study. Clin. Infect. Dis. 42:822-825.
9. Deepe, G. S., Jr. 2004. Preventative and therapeutic vaccines for fungal infections: from concept to implementation. Expert Rev. Vaccines 3:701- 709.
10. Flavia Popi, A. F., J. D. Lopes, and M. Mariano. 2002. GP43 from Paracoccidioides brasiliensis inhibits macrophage functions. An evasion mechanism of the fungus. Cell Immunol. 218:87-94.
11. Gobert, A. P., et al. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. U. S. A. 98:13844-13849.
12. Hu, X., and L. B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31:539-550.
13. Hung, C. Y., J. Xue, and G. T. Cole. 2007. Virulence mechanisms of coccidioides. Ann. N. Y. Acad. Sci. 1111:225-235.
14. Idnurm, A., J. L. Reedy, J. C. Nussbaum, and J. Heitman. 2004. Cryptococcus neoformans virulence gene discovery through insertional mutagenesis. Eukaryot. Cell 3:420-429.
15. Jimenez Mdel, P., L. Walls, and J. Fierer. 2006. High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression. Infect. Immun. 74:3387-3395.
16. Kakuda, D. K., M. J. Sweet, C. L. Mac Leod, D. A. Hume, and D. Markovich. 1999. CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages. Biochem. J. 340:549-553.
17. Livonesi, M. C., et al. 2009. Inducible nitric oxide synthase-deficient mice show exacerbated inflammatory process and high production of both Th1 and Th2 cytokines during paracoccidioidomycosis. Microbes Infect. 11:123- 132.
18. Lowenstein, C. J., and E. Padalko. 2004. iNOS (NOS2) at a glance. J. Cell Sci. 117:2865-2867.
19. McNeil, M. M., et al. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33:641-647.
20. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
21. Missall, T. A., et al. 2006. Posttranslational, translational, and transcriptional responses to nitric oxide stress in Cryptococcus neoformans: implications for virulence. Eukaryot. Cell 5:518-529.
22. Moreira, A. P., L. A. Dias-Melicio, M. T. Peracoli, S. A. Calvi, and A. M. Victoriano de Campos Soares. 2008. Killing of Paracoccidioides brasiliensis yeast cells by IFN-gamma and TNF-alpha activated murine peritoneal macrophages: evidence of H(2)O(2) and NO effector mechanisms. Mycopathologia 166:17-23.
23. Moreira, A. P., L. A. Dias-Melicio, and A. M. Soares. 2010. Interleukin-10 but not Transforming Growth Factor beta inhibits murine activated macrophages Paracoccidioides brasiliensis killing: effect on H2O2 and NO production. Cell Immunol. 263:196-203.
24. Nakamura, L. T., B. A. Wu-Hsieh, and D. H. Howard. 1994. Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immun. 62: 680-684.
25. Naslund, P. K., W. C. Miller, and D. L. Granger. 1995. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophagelike cells. Infect. Immun. 63:1298-1304.
26. Nicholson, B., C. K. Manner, J. Kleeman, and C. L. MacLeod. 2001. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J. Biol. Chem. 276:15881-15885.
27. Nittler, M. P., D. Hocking-Murray, C. K. Foo, and A. Sil. 2005. Identification of Histoplasma capsulatum transcripts induced in response to reactive nitrogen species. Mol. Biol. Cell 16:4792-4813.
28. Pullen, J. K., E. Eustis-Turf, M. J. Myers, and L. B. Schook. 1989. Regulation of MHC gene expression during the differentiation of bone marrowderived macrophages. Cell Immunol. 121:398-413.
29. Rada, B., and T. L. Leto. 2008. Oxidative innate immune defenses by Nox/ Duox family NADPH oxidases. Contrib. Microbiol. 15:164-187.
30. Silva, M. B., et al. 2009. Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18. Mem. Inst. Oswaldo Cruz 104:644-648.
31. Tohyama, M., K. Kawakami, M. Futenma, and A. Saito. 1996. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide. Clin. Exp. Immunol. 103:436-441.
32. Trajkovic, V., et al. 2000. Cryptococcus neoformans neutralizes macrophage and astrocyte derived nitric oxide without interfering with inducible nitric oxide synthase induction or catalytic activity-possible involvement of nitric oxide consumption. Scand. J. Immunol. 51:384-391.
33. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1996. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. 64:3127-3133.
34. Vieira, O. V., R. J. Botelho, and S. Grinstein. 2002. Phagosome maturation: aging gracefully. Biochem. J. 366:689-704.
35. Wüthrich, M., H. I. Filutowicz, T. Warner, and B. S. Klein. 2002. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J. Immunol. 169:6969-6976.
36. Wüthrich, M., et al. 2011. Vaccination against the North American Systemic Mycoses requires T17 cells in mice. J. Clin. Invest. 121:554-568.
37. Xiao, G., et al. 2008. Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharides. Microbiol. Immunol. 52:171-179.